Hartford Investment Management CO Repligen Corp Transaction History

Hartford Investment Management CO

  • $2.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 29, 2019
SELL
$49.45 - $62.8 $296,156 - $376,109
-5,989 Closed
0 $0
Q3 2018

Nov 08, 2018
SELL
$46.8 - $58.97 $18,673 - $23,529
-399 Reduced 6.25%
5,989 $332,000
Q2 2018

Jul 19, 2018
BUY
$35.26 - $47.04 $225,240 - $300,491
6,388 New
6,388 $300,000

Others Institutions Holding RGEN

# of Institutions
489
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email